Galmed Announces A Delay Of At Least Six Months In The Initiation Of Its Primary Sclerosing Cholangitis (PSC) Phase 2a Study
Galmed Announces A Delay Of At Least Six Months In The Initiation Of Its Primary Sclerosing Cholangitis (PSC) Phase 2a Study
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.